Omkar Speciality Chemicals Ltd. (NSE: OMKARCHEM) is a Thane, Maharashtra-based company in the Custom Synthesis and Specialty CDMO industry. With a market capitalisation of ₹7 Cr, it ranks #4,908 by market cap among the 6,197 Indian listed companies on FinBizNet, and #13 of 13 in Custom Synthesis and Specialty CDMO. At ₹3.41 (as of 16 Nov 2026), the share price is 46.3% below its 52-week high of ₹6.35 and 1.8% above its 52-week low of ₹3.35. The share price is down 36.0% over one year and up 0.0% over three months.
| Current Price | ₹3.41 |
|---|---|
| Market Cap | ₹7 Cr |
| NSE Symbol | OMKARCHEM |
| Sector | Materials > Chemicals > Speciality Chemicals |
| Sub-Industry | Specialty Chemicals > Custom Synthesis and Specialty CDMO |
| P/E Ratio | Not meaningful (loss) |
| Return on Equity | 7.65% |
| Return on Assets | -2.12% |
| 52-Week Range | ₹3.35 – ₹6.35 |
| 1-Year Price Change | -36.0% |
| 3-Month Price Change | 0.0% |
| Beta (1Y) | 0.37 |
| Dividend Yield | 0.00% |
| Headquarters | Thane, Maharashtra |
| Website | www.omkarchemicals.com |
| Revenue | ₹0 Cr |
|---|---|
| Net Profit | ₹-1 Cr |
| EPS (Basic) | ₹-0.47 |
| Basis | standalone |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Omkar Speciality Chemicals Ltd. reported revenue of ₹0 Cr in Q2 FY27, against ₹0 Cr in Q2 FY26 and against ₹0 Cr in Q1 FY27. It posted a net loss of ₹1 Cr for the quarter, against a net loss of ₹1 Cr in Q2 FY26. Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹0 Cr (Q2 FY27) to ₹0 Cr (Q4 FY26). The company reported a net loss in 7 of these 7 quarters.
| Quarter | Revenue | Net Profit | Net Margin |
|---|---|---|---|
| Q2 FY27 | ₹0 Cr | −₹1 Cr | — |
| Q1 FY27 | ₹0 Cr | −₹0 Cr | — |
| Q4 FY26 | ₹0 Cr | −₹0 Cr | −3300.0% |
| Q3 FY26 | ₹0 Cr | −₹0 Cr | — |
| Q2 FY26 | ₹0 Cr | −₹1 Cr | — |
| Q1 FY26 | ₹0 Cr | −₹0 Cr | — |
| Q4 FY25 | ₹0 Cr | −₹0 Cr | — |
Standalone figures (₹ crore, XBRL filings).
Promoters held 4.94% of Omkar Speciality Chemicals Ltd.'s shares as of Sept 2026, unchanged from Sept 2025.
Omkar Speciality Chemicals Ltd. made 3 exchange disclosures in the Corporate Insolvency Resolution Process (CIRP) category between 25 Dec 2024 and 1 Aug 2025. The filings refer to a Committee of Creditors or a Resolution Professional, the bodies that run a CIRP under the Insolvency and Bankruptcy Code, 2016. The most recent specific filing, dated 25 Dec 2024, reads: "Corporate Insolvency Resolution Process, Post Facto intimation of 12th CoC meeting held on 23rd December, 2024."
Taken from the company's own stock exchange filings. FinBizNet does not infer the current status of any proceeding.
Omkar Speciality Chemicals Limited manufactures and sells specialty chemicals and intermediates for chemical and allied industries in India and internationally. It provides a range of organic, inorganic, and organo inorganic intermediates. The company offers selenium derivatives, iodine derivatives, resolving agents, and advance intermediates, as well as tartaric acid derivatives and other intermediates. Its products have applications in the pharmaceuticals, neutraceuticals, fragrances and flavours, foods, poultry and veterinary, glass and ceramics, and electro plating segments. The company also exports its products to Europe, Canada, Asia, South America, and Australia. Omkar Speciality Chemicals Limited was incorporated in 1983 and is based in Thane, India.
1. Manufacturing and Sale of Chemicals-This segment researches, develops, manufactures, and sells specialty chemicals, human and veterinary bulk drugs, and pharma intermediates, as well as inorganic molecules having applications as feed ingredients, micro nutrients, etc.
1. Manufacturing and Sale of Speciality Chemicals-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Anupam Rasayan India Ltd | ₹13,570 Cr | 79.6 | 5.76% | ₹806 Cr | +20.1% |
| Neogen Chemicals Limited (Neogen) | ₹8,322 Cr | 259.2 | 3.58% | ₹296 Cr | +93.4% |
| Prasol Chemicals Limited | ₹4,681 Cr | 58.1 | — | ₹413 Cr | — |
| Laxmi Organic Industries Ltd | ₹4,574 Cr | 57.2 | 4.08% | ₹1,083 Cr | -18.9% |
| Tatva Chintan Pharma Chem Ltd | ₹3,871 Cr | 92.5 | 5.53% | ₹217 Cr | +12.2% |
| Paushak Ltd. | ₹1,487 Cr | 38.1 | 8.22% | ₹89 Cr | — |
| Sunshield Chemicals Ltd. | ₹833 Cr | 25.2 | 17.02% | — | +12.6% |
| Chemcon Speciality Chemicals Limited | ₹733 Cr | 31.8 | 4.80% | ₹65 Cr | -12.8% |
| Omkar Speciality Chemicals Ltd. | ₹7 Cr | n/m | 7.65% | ₹0 Cr | -36.0% |
Listed by market capitalisation. Ratios are shown for context only.
Omkar Speciality Chemicals Ltd. is trading at ₹3.41, with a market capitalisation of ₹7 Cr.
Omkar Speciality Chemicals Ltd. operates in the Materials > Chemicals > Speciality Chemicals space (Specialty Chemicals > Custom Synthesis and Specialty CDMO).
Omkar Speciality Chemicals Ltd. has a return on equity of 7.65%.
Omkar Speciality Chemicals Ltd. is listed on the NSE under the symbol OMKARCHEM.
Omkar Speciality Chemicals Ltd.'s share price is down 36.0% over one year and up 0.0% over three months. Its 52-week range is ₹3.35 to ₹6.35.
In Q2 FY27, Omkar Speciality Chemicals Ltd. reported revenue of ₹0 Cr and net profit of ₹-1 Cr, with basic EPS of ₹-0.47 (standalone, parsed from the company's exchange filing).
Omkar Speciality Chemicals Ltd. reported revenue of ₹0 Cr in Q2 FY27, against ₹0 Cr in Q2 FY26 and against ₹0 Cr in Q1 FY27.
Promoters held 4.94% of Omkar Speciality Chemicals Ltd.'s shares as of Sept 2026, unchanged from Sept 2025.
Omkar Speciality Chemicals Ltd. made 3 exchange disclosures in the Corporate Insolvency Resolution Process (CIRP) category between 25 Dec 2024 and 1 Aug 2025. The filings refer to a Committee of Creditors or a Resolution Professional, the bodies that run a CIRP under the Insolvency and Bankruptcy Code, 2016. The most recent specific filing, dated 25 Dec 2024, reads: "Corporate Insolvency Resolution Process, Post Facto intimation of 12th CoC meeting held on 23rd December, 2024."
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.